Metabolic and signaling pathways in steatosis and steatohepatitis

Metabolic and signaling pathways in steatosis and steatohepatitis - steatosis and steatohepatitis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31033

Enrollment

Registered

2007-09-04

Start date

2007-10-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

corpulence obesity

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: adult women and men partial hepatectomy or open liver biopsy

Exclusion criteria

Exclusion criteria: alcohol abuse drugs damaging the liver hepatitis C and B

Design outcomes

Primary

Measure	Time frame
1) Histopathological score in the different stages of NAFLD. 2) Gene expression profile in micro-array study.	—

Secondary

Measure	Time frame
not of application	—

Countries

Netherlands

Outcome results